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Abstract
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Introduction—Earlier identification of children with prenatal alcohol exposure (PAE) remains a
challenge. The objective of this study was to identify neurobehavioral (NB) outcomes associated
with PAE in infants.
Methods—This manuscript evaluates NB outcomes at 6.33±1.12 months of age in 93 infants (39
PAE and 54 No-PAE) recruited prospectively into the ENRICH cohort. PAE was assessed by
prospective repeated TLFB interviews and a panel of ethanol biomarkers. NB outcomes were
evaluated by the Bayley Scales of Infant Development (BSID-III), Parenting Stress Index (PSI),
Infant Behavior Questionnaire (IBQ-R), and Infant Sensory Profile (ISP).
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Results—Mean maternal age at enrollment was 28.18 ±5.75, and 64.52 % were Hispanic/Latina.
Across three TLFB calendars, absolute alcohol per day in the PAE group was 0.44±0.72,
corresponding to low-moderate alcohol consumption. While no association was observed between
PAE and BSID-III (p’s>0.05), PAE was associated with higher scores on the PSI difficult child
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scale (β̂ =13.9; p=0.015), total stress (β̂ =13.9; p=0.010), and IBQ negative affect (β̂ =8.60;
p=0.008) measures after adjustment for covariates.
Conclusions—Caregiver-reported assessments may provide a currently unrecognized
opportunity to identify behavioral deficits, point to early interventions, and should be included in
clinical assessments of infants at-risk for FASD.

INTRODUCTION

Author Manuscript

An estimated 18% of U.S. pregnancies are affected by prenatal alcohol exposure (PAE) (1).
PAE can result in the development of lifelong disabilities, collectively termed Fetal Alcohol
Spectrum Disorders (FASD). Recent reports indicate that FASD prevalence is much higher
than previously thought and might affect as many as 2–5% of school-aged children (2).
While FASD is associated with a wide range of adverse physical and neurological
impairments, many individuals on the spectrum have severe neurobehavioral (NB) deficits
without characteristic physical features, potentially hindering their early and accurate
diagnosis and access to appropriate interventions. A diagnosis of FASD commonly is not
reached until an affected child is well into school-age years. A recent study demonstrated
that as many as 86.5% of school-aged children with FASD are undiagnosed or misdiagnosed
(3). Such challenges in early and accurate identification can be attributed to lack of training
and awareness among medical and education professionals, challenges related to differential
diagnosis, co-occurrence of FASD with other neurodevelopmental disorders(4), and the
dearth of validated behavioral screening and diagnostic tool, particularly for use in infants
and toddlers. Without early and effective interventions, these NB deficits can lead to
secondary adverse outcomes, such as poor academic performance and sociability,
unemployment, substance abuse, homelessness, and incarceration (5).

Author Manuscript
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The neuropsychological profile of persons with FASD is marked by profound variability,
potentially affecting a number of different domains including executive function, learning
and memory, language, visual-spatial skills, motor function, attention and activity, academic
performance, and behavior (6). It has been widely-agreed that a variety of standardized
measures be incorporated in clinical evaluations for FASD; thus, numerous NB assessments
have been studied for screening and diagnostic purposes. These assessments have been
heavily concentrated in children of preschool-age or older, with findings from preschool-age
samples suggesting possible feasibility in extending NB assessment to even younger
populations (7, 8). Molteno et al. found that diminished competence in symbolic play at 13
months (9) and emotional withdrawal at 6.5 months of age (10) were significantly altered in
PAE infants from a South African cohort; findings at 6.5 months were significantly
predictive of low IQ at a 9-year follow-up. In another South African cohort, Davies et al.
found that infants and toddlers with full and partial fetal alcohol syndrome (FAS, pFAS)
performed worse than those without FAS or pFAS on all sub-scales and on the total
development quotient of the Griffith’s Mental Development Scale (11). A prospective cohort
study in Ukraine found that PAE was associated with lower Mental Development Index on
the Bayley Scales of Infant Development-II (BSID-II) (12), and alterations in the cardiac
orienting response at 6 and 12 months of age (13). In an earlier study at the University of

Pediatr Res. Author manuscript; available in PMC 2018 December 28.

Bakhireva et al.

Page 3

Author Manuscript

New Mexico, we demonstrated altered emotional regulation and stress reactivity during the
Still Face paradigm in 5–7 month old infants affected by PAE (14).
While the published results are limited, they support the hypothesis that neurobehavioral
deficits related to PAE may be detectable in children younger than 2 years of age. Given that
higher-order neurobehavioral domains, such as executive functioning, only begin to emerge
around 18 months of age, early identification of children affected by PAE remains one of the
biggest challenges in the field. The objective of this prospective cohort study was to identify
NB indices associated with moderate PAE in 5–8 month old infants. We hypothesized that
impairments in self-regulation and sensory processing domains will be more sensitive
measures of PAE than NB indices obtained on standardized global assessment tests, such as
BSID. The long-term goal of our program is to refine analytical procedures with greater
utility for the identification of children with PAE at an earlier stage in development.

Author Manuscript

METHODS
Study design and population
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The data for this study were obtained from the prospective birth cohort, Ethanol,
Neurodevelopment, Infant and Child Health (ENRICH), at the University of New Mexico
(UNM), the methodology of which has been described elsewhere (15). Briefly, this study
consists of four visits: enrollment and baseline data collection obtained during pregnancy
(Visit 1 [V1]), evaluation during the hospital stay after labor and delivery (Visit 2 [V2]), a 5–
8 month assessment of the infant (Visit 3 [V3]), and a 20–24 month follow-up assessment
(Visit 4 [V4]). All study activities were reviewed and approved by the UNM Health Sciences
Center Human Research Protections Program, and all participants provided written informed
consent. The study began in 2013, and as of September 2017, 93 maternal-infant dyads had
completed the first three visits and were included in the analyses presented in this
manuscript. The retention rate was 72.1%.
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Participants were recruited from UNM hospital-affiliated prenatal care clinics, including a
specialty prenatal care program, called Milagro, which exclusively treats pregnant and
postpartum women with substance use disorders. Participants were recruited into four study
groups: (1) PAE; (2) medication-assisted therapy (MAT) with opioid agonists for opioid use
disorder; (3) PAE+MAT; and (4) unexposed/healthy controls (HC). Individuals with MAT
were included to better match pre- and post-natal environmental factors and socio-economic
status (SES) across groups. Among subjects on MAT, 17 were on methadone, 22 on
buprenorphine, and 2 had exposure to both regiments. To examine the primary hypothesis
regarding the effects of PAE on infant development these four groups were combined into
two: PAE (PAE with or without MAT) and No-PAE (MAT and HC).
Inclusion criteria for all study groups include: 1) a singleton pregnancy, 2) enrolled between
12 and 35 gestational weeks, 3) delivered at UNM hospital, 4) planning to reside in New
Mexico for 2 years to complete all study visits, and 5) ability to provide written consent in
English. Exclusion criteria include: 1) fetal diagnosis of a major structural abnormality; 2)
more than occasional (>1 urine drug test or more than monthly) use of cocaine,
methamphetamines, or MDMA during the first trimester and any use of these substances in
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the second or third trimesters as determined by either self-report, positive urine drug screen,
or medical records review. Study participants in the PAE, MAT, and PAE+MAT groups were
not disqualified due to concurrent use of nicotine or non-stimulant substances of abuse (e.g.,
marijuana). HC participants were those who reported no alcohol use after the last menstrual
period (LMP), tested negative on all biomarkers (described below), and were abstainers from
tobacco and illicit drug use. During recruitment, the goal was to frequency match groups on
SES, and recruitment was adjusted throughout to best match groups.
Assessment of Prenatal Alcohol Exposure

Author Manuscript

PAE was assessed by repeated prospective Timeline Follow-Back (TLFB) (16) 30-day
calendar interviews and a comprehensive battery of ethanol biomarkers. At baseline
(prenatal/V1), TLFB was administered for the periconceptional period (2 weeks before and
2 weeks after the LMP; TLFB1), and the 30 days leading up to enrollment (TLFB2). At V2
(delivery), TLFB was administered for the 30 days preceding the visit (TLFB3). Moreover,
alcohol use during ‘special occasions’ outside of these time periods was also recorded. In
addition to self-report, this study involved assessment of a battery of ethanol biomarkers. At
V1, gamma-glutamyl transpeptidase (GGT), carbohydrate deficient transferrin (CDT), and
phosphatidylethanol (PEth) were analyzed from maternal blood specimens. At V2, GGT,
CDT, and PEth analyses were repeated and supplemented with maternal urine
ethylgucuronide (uEtG) and ethylsulfate (uEtS), and PEth in a newborn dry blood spot card
(PEth-DBS). Collection and laboratory processes pertaining to these biomarkers have been
described in detail elsewhere (15, 17).

Author Manuscript
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Participants who report more than minimal-risk alcohol use (>13 standard drink units
[SDU]/month) or ≥ 2 binge episodes in the periconceptional period and continue to use
alcohol during pregnancy (as evident by alcohol use on TLFB2 or TLFB3 or positivity on ≥
1 ethanol biomarker) met criteria for the PAE groups. Initial categorization was based on the
TLFB1 since hazardous drinking in the periconceptional period is highly predictive of
alcohol use later in pregnancy, is reported more openly (16), and is a good predictor of infant
neurodevelopmental outcomes later in life (12). Confirmation by TLFB2, TLFB3, and
ethanol biomarkers was done to ensure PAE exposure after pregnancy recognition. These
criteria, incorporating ‘more than minimal’ risk alcohol exposure levels, are consistent with
the definition of PAE in the DSM-5 proposed classification for neurodevelopmental disorder
associated with PAE (ND-PAE) (18). Subjects were classified into non-PAE groups if they a)
reported no more than ‘light’ drinking (≤2 drinks/week) in the periconceptional period, b)
reported abstinence from alcohol use during pregnancy (all 3 TLFB calendars and special
occasions), and c) tested negative on all ethanol biomarkers. Subjects who initially were
classified into the control groups but later tested positive for ethanol biomarkers were
disqualified and did not continue to V3.
Assessment of Neurobehavioral Outcomes
At V3 (5–8 month infant assessment), NB outcomes were assessed using a battery of
validated measures. This included the administration of gross motor, fine motor, cognitive,
and language scales of the BSID-III by a pediatric developmental diagnostician (JL), who
was blinded to the exposure status. In addition, a number of validated caregiver
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questionnaires were administered to assess: 1) quality of parent-child interactions and
parenting stress (Parenting Stress Index-Short Form [PSI-SF]); 2) infant temperament
(Infant Behavior Questionnaire-Revised [IBQ-R]; and 3) infant sensory processing and
reactivity (Infant/Toddler Sensory Profile [ISP]). Specific domains evaluated by each
instrument are summarized in Table 1. All assessments were scored by trained members of
the research team who were blinded to participants’ exposure status. At the baseline visit,
patients were encouraged to discuss alcohol use with their healthcare providers; the majority
already were receiving comprehensive care through the Milagro program. At the completion
of V3, all participants received a summary of infant neurodevelopmental assessment;
necessary referrals to early intervention programs were made.
Assessment of Covariates

Author Manuscript

Prenatal exposure to all major substances of abuse (nicotine, cocaine, methamphetamines,
3,4-methylenedioxymethamphetamine [MDMA or ‘ecstasy’], nonmedical use of opioid
analgesics, heroin, marijuana/cannabinoids, benzodiazepines, and barbiturates) was assessed
by repeated maternal report, a study-specific 7-panel urine drug test analyzed by Tricore
Reference Laboratories (Albuquerque, New Mexico), and abstraction of urine drug screen
results from electronic medical records (EMR) (15). Maternal demographic, socioeconomic,
medical, and reproductive health characteristics were collected at V1, and birth outcomes
were abstracted from participants’ EMR. Maternal Perceived Stress Scale (PSS) (19) was
administered at V2 to capture maternal perceived stress at the end of pregnancy (30 days
before delivery). Additionally, postnatal risk factors were assessed at V3, including maternal
depressive symptoms (Beck Depression Inventory [BDI]), household income, and utilization
of social services and participation in early intervention programs.

Author Manuscript

Statistical Analyses
Power calculations were done a priori for the BSID-III assuming a population mean of 100
with SD=15. With sample sizes of 39 and 54, we had 93.4% power to detect a 10-point
difference between the study groups. This difference translates to Cohen’s d effect size of
0.67, where d=0.2 is considered a 'small' effect size, 0.5 represents a 'medium' effect size,
and 0.8 a 'large' effect size. The sample size of 93 subjects is sufficient to adjust for 9
covariates in a multiple linear regression setting while maintaining at least 10 subject per
variable (SPV) which in turns assures no overfitting.

Author Manuscript

Numerical and graphical summaries were computed for all measurements obtained from the
maternal prenatal and early postpartum interviews and results of laboratory analyses. T-tests
and Chi-square tests were used to compare mean and proportions of continuous and
categorical variables, respectively, between the study groups. For variables not normally
distributed (e.g. BDI), the Wilcoxon Rank Sum test for differences in medians was used.
Linear regression was conducted to investigate the effect of PAE on continuously distributed
infant outcomes (i.e., BSID, PSI, and IBQ scores). Ordinal sensory profile variables (less
than others, typical performance, more than others) were dichotomized into atypical
performance (less/more than others) vs. typical performance. The binary logistic regression
was conducted to investigate the effect of PAE before and after adjustment of covariates on
these outcomes. For multivariable analyses, a list of covariates was selected a priori based on
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known risk and resilience factors affecting infant neurodevelopmental outcomes (i.e., infant
sex, birth weight, single vs. two-parent household, BDI, maternal education, maternal age)
and co-exposures that were differentially distributed between the study groups (i.e., MAT,
marijuana, tobacco use); all considered to be biologically meaningful. Of note, while the
PAE group had a higher prevalence of preterm delivery, gestational age at delivery was not
included as a covariate due to its strong collinearity with birth weight (tolerance≈0.44,
VIF=2.3, Pearson correlation coefficient 0.68; p<0.0001) and because infant age at V3
assessment was already adjusted for prematurity. A sensitivity analysis was conducted to
identify the best subset of covariates using a stepwise backwards selection procedure. The
results of the best subset models were similar to those of the full models, thus results were
presented after adjustment for a full set of covariates as a more conservative approach. In
addition to the reported p-values, measures of effect size (partial eta squared) were provided
to assist in better interpretation of the finding where η2=0.01, η2=0.06 and η2 =0.14 indicate
small, medium, and large effect sizes, respectively.

Author Manuscript

RESULTS

Author Manuscript

The mean maternal age at enrollment was 28.18 ± 5.75 years, and the majority of subjects
were recruited during the second trimester (gestational age at enrollment: 24.46±7.36
weeks). There were no significant differences in socio-demographic and medical
characteristics (age, ethnicity, marital/co-habituating status, education, gravidity, SES, Beck
Depression Inventory, annual family income) between the study groups except race. While
the study recruited 64.5% Hispanic Latina women who were similarly distributed between
two study groups, the PAE group included a higher proportion of other minorities compared
to the No-PAE group (p=0.010). Additionally, a higher proportion of subjects in the PAE
group partricipated in early intervention program (58.3% vs. 35.1%); however, differences
did not reach statistical significance (p=0.087). Subjects in the PAE group also had a higher
mean PSS score compared to No PAE (13.4 ± 5.7 vs. 10.0 ± 4.9, respectively; p=0.003).
With respect to pregnancy outcomes, the PAE group had a higher prevalence of preterm
delivery (25.6% vs. 5.6%) and lower infant birth weight (2,881±699g vs. 3,209±582g; both
p’s<0.05). Infant age at V3 assessment was similar in both groups.

Author Manuscript

In accordance with the eligibility criteria, the No-PAE group reported minimal alcohol use in
the periconceptional period (0.003±0.009), no alcohol use beyond the periconceptional
period, and tested negative on all ethanol biomarkers at V1 and V2 (Table 3). The PAE
group reported heavy/risky alcohol use in the periconceptional period (1.27±2.16 AA/day,
equivalent to approximately 18 standard drinks per week) with, on average, 7.24±8.97 binge
drinking episodes per reported 30-day calendar. The alcohol consumption decreased later in
pregnancy, with the reported AA/day at V1 being only 0.05±0.25 (equivalent to 0.7 standard
drinks/week). Across three TLFB calendars, AA/day in the PAE group was 0.44±0.72
(equivalent to approximately 6 drinks/week), which is considered moderate drinking (20).
Notably, 53.9% of subjects in the PAE group tested positive for at least one ethanol
biomarker at either V1 or V2. Consistent with the eligibility criteria, 56.4% and 35.2% of
patients in the PAE and No-PAE groups, respectively, were receiving MAT (p=0.057). Coexposure with other opioids was also prevalent but similar in both groups (p=0.105).
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Marijuana use (35.9% vs. 11.1%) and tobacco use (53.9% vs. 27.8%) were more prevalent
in the PAE group (both p’s <0.05).
Infant developmental and behavioral outcomes by study group are presented in Table 4. No
differences in the BSID-III cognitive, language, or motor scores were observed between
PAE and No-PAE subjects (p’s>0.05). On the Parenting Stress Index (PSI) and Infant
Behavior Questionnaire (IBQ), children in the PAE group had higher scores for parent-child
dysfunctional interaction (p=0.019), difficult child (p=0.011), total stress score (p=0.011),
and infant negative affect (p=0.011) compared to the No-PAE group. No differences were
observed between the groups for the Sensory Profile indices (p>0.05).
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Results of multivariable analyses demonstrated that PAE was associated with higher scores
on the PSI difficult child (β̂ =13.9; p=0.015, total stress (β̂ =13.9; p=0.010, and IBQ negative
affect (β̂ =8.60; p=0.008) scales after adjustment for infant sex, birth weight, single vs. twoparent household, maternal BDI, PSS, education, age, MAT, marijuana, and tobacco use. In
addition, trends were observed for an association between PAE and BSID Cognitive scale (β̂
=3.44), PSI parent-child dysfunctional interaction (β̂ =9.64), and IBQ surgency subscale (β̂
=4.91); all p-values <0.1. There was also a trend for an association between PAE and a
pattern of atypical sensory sensitivity (OR=2.29; 95% CI: 0.93; 5.64) in the unadjusted
model; however, results became non-significant after adjusting for covariates. Finally, no
significant interactions were observed between PAE and infant sex with respect to any of the
evaluated outcomes (all p-values > 0.05; results not shown).

DISCUSSION
Author Manuscript

Our results demonstrate that while global neurodevelopmental tests, such as BSID, might
not yet identify deficits associated with PAE at 6 months of age, particularly moderate/light
PAE, caregiver-reported assessments may provide an under-recognized opportunity to
identify neurodevelopmental and behavioral concerns for infants with PAE. Temperament
and behavioral characteristics, as well as sensory sensitivity of 6-month-old infants with
PAE may be measurably altered. One of the striking findings earlier described by Streissguth
et al. is that children with FAS and ‘fetal alcohol effects’ have better long-term outcomes
when identification/diagnosis is obtained at a young age (21). This finding has largely been
attributed to the ability to begin subsequent interventions early that then led to better longterm outcomes. Therefore, additional measures that assess infant behavior and sensory
processing may improve our ability to identify infants with PAE who may benefit from early
intervention.

Author Manuscript

The 2016 Hoyme updated clinical guidelines for diagnosing Fetal Alcohol Spectrum
Disorders (FASD) outline the following three critical domains to be assessed in children atrisk: 1) global intellectual ability; 2) behavior and self-regulation; and 3) adaptive skills (22).
Our study indicates that measures of impaired emotional regulation (e.g. negative affect,
‘difficult child’ rating) might be evident in 6-month old children before deficits in other
domains become apparent. Similar to our findings of increased negativity associated with
PAE, two other studies reported increased stress reactivity and negative affect in infants with
PAE seen at 5 to 7 months of age (14, 23). A longitudinal study by Molteno and colleagues
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(10) found that 13-month-old infants with FAS had greater emotional withdrawal and
decreased activity, while emotional withdrawal was also a significant predictor of a reduced
IQ score at 9 years of age. These studies support our findings of emotional regulation
difficulty and specifically ratings of higher negativity for those children with alcohol and
drug exposure.

Author Manuscript

Children exposed to alcohol are also at higher risk for attachment problems and altered
mother-infant interactions. Impairments in caregiver-child interaction and higher level of
parental stress in families affected by PAE, found in our study, are concerning because the
first year life is an important period for maternal-infant bonding. Prior research has
demonstrated that parental bonding and parental stress impact cognitive and behavioral
outcomes in children, including executive functioning (24). In a recent review, Parolin &
Simonelli described the association between maternal substance abuse, which is often
associated with dysfunctional caregiving environments, and attachment problems for the
child (25). Newcomb and Locke found that substance use affected the parents’ likelihood to
show warmth, read their infant’s cues, and predicted a style of parenting that included
rejecting the child (26). It is, therefore, not surprising that we found the infants in this study
were rated by their primary caregivers to have higher scores on parent-child dysfunctional
interaction. Caregiver’s rating of their infant as ‘difficult’ on the PSI may be an indicator of
parenting difficulty specifically related to the mother-child interaction. Emerging research
indicate that caregivers raising children with FASD experience high level of stress and wellbeing concerns, especially low income families, those who care for adolescents (27), and
have limited family reources (28). While research in this field is in formative stages, recent
studies indicate that targeted family intervention programs (29) and parent training (30)
might alleviate caregiver distress.
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Our finding that the BSID-III only marginally sensitive to group differences was not
surprising due to the limited sensitivity and predictability of the scale at this age; however
the study might have been under-powered to detect less than 10-point differences in the
BSID. Earlier versions of the BSID were used in several prospective cohort samples of U.S.
infants with PAE during the 1980s and 1990s. While one of these studies found lower
mental and motor BSID-II scores among 8-month-olds with PAE, the magnitude of
decrement in the PAE group compared to controls was only slight (31). Other similar studies
found no significant group differences with the BSID-II among PAE vs. control infants less
than one year of age, and mixed results in later follow-up of the infants between 12 and 24
months of age (32–35). While some more recent studies have identified neurodevelopmental
deficits in infants with PAE during the first year of life using the BSID-II (12), there is
increasing agreement that other measures might be more sensitive and specific (13, 14, 36).

Author Manuscript

While we are not aware of any studies that have explored the ability to detect sensory
processing deficits in a PAE population during the first year of life, limited existing data
suggest that children with FASD who are of preschool age or greater may have significant
abnormalities in multiple domains of sensory processing, and that these deficits may be
related to other problem behaviors commonly observed with FASD (37–39). In a study of
children 5 to 10 years with FASD, Franklin and associates (2008) found that parents
reported that up to 84% of the children with a diagnosis of FASD had both problem
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behaviors and sensory-processing impairments (37). A high correlation was also found
between parents report on Dunn’s Sensory Profile and the the Child Behavior Checklist
(CBCL). This supports the importance of including these types of parent report measures in
studies of early identification of sensory problems that are associated with later problem
behaviors. Animal studies show a consistent delay in auditory processing in animals with
PAE suggesting that impaired myelination may play a role (40). Other studies indicate that
somatosensory processing is also affected with evidence that the somatosensory cortex has
reduced cortical representation in rats – an 11% reduction in forepaw representation (41).
Xie et al. (42) extended these findings to low exposure groups by demonstrating a similar
pattern of reduced forepaw representations in somatosensory cortex. This is also consistent
with our prior studies indicating delays in auditory (43) and visual (44) processing. The
pattern of either sensory under- or over- sensitivity is consistent with other
neurodevelopmental disorders, such as Autism Spectrum Disorder, in which sensory over-/
under- sensitivity is now considered one of the diagnostic criteria in the DSM-5. While it is
unclear what underlying mechanisms lead to sensory sensitivity, these prior studies provide
evidence for sensory processing deficits in human and animals studies of PAE.

Author Manuscript

This study has a number of strengths relative to prior studies on PAE. One of the primary
strengths was the prospective cohort design in which mothers were assessed for alcohol
consumption while pregnant. The same infants were followed to 6 months of age providing
documented evidence of PAE rather than depending on retrospective self-report. This cohort
also included infants with co-exposures, which is important since growing research
acknowledges that polysubstance use in pregnancy is prevalent in the U.S. (45), and poses
additional risks and challenges for the maternal-child pair. An additional strength was the
inclusion of women on MAT, which served the purpose of controlling for environmental
confounds such as socioeconomic status. As shown in Table 2, the PAE and No-PAE groups
were well matched on educational level, family income, total SES score and BDI score,
which have previously been shown to impact infant development.
The results reported here are relevant to women who report moderate-to-low levels of
alcohol consumption. In the DSM-5, a new diagnostic category, Neurodevelopmental
Disorder Associated with PAE (ND-PAE), was introduced under “Conditions for further
study,” defining the PAE risk threshold as >13 drinks/month during pregnancy, but calling
for prospective longitudinal research on the effects of this exposure level (18). Thus, our
study on early physiological and behavioral indices associated with this level of exposure is
addressing this call. Another strength of the ENRICH cohort is a state-of-the-art assessment
of PAE with prospective repeated TLFB interviews during pregnancy and a comprehensive
battery of ethanol biomarkers assessed twice.

Author Manuscript

This study is not without limitations with one of the main limitations being the relatively
small sample size. The prospective design and the additional assessment of functional brain
development (to be reported separately) limited the scope of the study to a wellcharacterized longitudinal sample as opposed to a larger cross-sectional sample. Despite this
moderate sample size, differences in behavioral measures were identified; however
additional studies will be needed to replicate the reported findings. Second, this cohort
includes individuals with other co-exposures. The individuals with MAT were included as a

Pediatr Res. Author manuscript; available in PMC 2018 December 28.

Bakhireva et al.

Page 10

Author Manuscript

part of the initial study design to control for socioeconomic factors and were represented in
both the control and the PAE groups. Within the MAT patient groups, there were coexposures with other substances, as expected, but patients who consumed stimulants were
excluded based on the known neurological effects. To account for these co-exposures we
adjusted for tobacco and marijuana consumption in multivariable modeling. Third, we
recognize that caregiver-reported outcomes might be more prone to recall bias relative to
investigator-administered assessments such as BSID and functional neuroimaging outcomes.
However, given low-moderate levels of exposure in the cohort we consider it highly unlikely
that knowledge about prior PAE resulted in differential reporting of infant behavior.
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Finally, we recognize that other pre- and postnatal factors not specifically evaluated in this
study, e.g. early childhood adversity, postnatal maternal substance use, are important
predictors of infant behavioral outcomes and parent-child attunement. However, in this
sample there were only 2 children with protective services involvement. The distribution of
key environmental factors (maternal education, family income, maternal BDI, involvement
in early intervention programs) was similar between the groups. In addition, in a subset of
53 subjects who have completed Visit 4 (20 month evaluation), no differences were observed
in the number of places child lived since birth (1.8±0.6 in PAE vs. 1.6±0.6 in No-PAE
groups). The effect of socioenvironmental factors is minimized in our study since the PAE
and No-PAE groups had similar SES background and substance use by design.

Author Manuscript

Based on the known limitations and the results of the current study, we envision important
future directions. First, it is important to understand the longer-term effects of PAE on
outcome and the ENRICH study is designed to follow the children to 20 months of age to
assess early markers of neurobehavioral delays in PAE children. Data collection is ongoing
and further results will be presented in future publications. While results presented in this
study were adjusted for birth weight (which was highly collinear with gestational age of
delivery) and the age of neurodevelopmental assessment was adjusted for prematurity, effect
of birth weight and gestational age at delivery on ND outcomes should be carefully
examined in larger future studies. The limited sample size also restricted the analysis that
could be performed with the current dataset examining different patterns of exposure
throughout pregnancy, including timing, quantity and frequency of drinking, as well as sex
differences with respect to NB outcomes.

Author Manuscript

In summary, we believe this is the first study showing group differences in behavioral
problems as early as 6 months of age in children with moderate prenatal alcohol exposure.
The current results indicate that parental questionnaires may be able to provide an indication
of PAE and may also point to potential areas as a target for early intervention. In particular,
parents reported higher scores on the PSI in PAE children, suggesting that family counseling
and other supportive family-centered interventions may be beneficial, even at this early age.
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Table 1
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Assessment Battery of Infant Outcomes
Domain

Instrument - Subscale

Subscale Description

Infant

BSID-III

Development

• Cognitive

Novelty interest/attention, problem-solving, pretend play

• Language

Receptive and expressive communication

• Motor

Fine and gross motor skills

Infant

Infant Behavior Questionnaire-R

Temperament

• Surgency

Externalizing behaviors

• Negative Affect

Fearfulness, emotional distress

• Effortful Control

Self-regulation (inhibitory control, attentional regulation, activational control)

Parenting Stress Index-Short
Disruptive or destructive behaviors likely to contribute to a parent's stress

Author Manuscript

• Difficult child
Parental Stress

Parenting Stress Index-Short
• Parent-child dysfunctional interaction

Quality of interactions, parent's relationship expectations and satisfaction

• Parental distress

Parent's personal adjustment to parenting, parent's relationship with child's other
parent (e.g., spouse), other life stressors

Infant Sensory

Infant/Toddler Sensory Profile

Processing

• Seeking

Interest in & pleasure with stimuli

• Sensitivity

Ability to notice sensations

• Avoiding

Effort to control or minimize sensations

Author Manuscript
Author Manuscript
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Table 2

Author Manuscript

Demographic and Medical Characteristics of Participants (N=93)
Patient Characteristics

PAE
(n=39)

No-PAE
(n=54)

p

Author Manuscript

Mean ± SD

Mean ± SD

Maternal age at enrollment (years)

28.95 ± 5.88

27.63 ± 5.64

0.2 77

Gestational age at enrollment (weeks)

25.69 ± 6.99

23.58 ± 7.56

0.174

Gestational age at delivery (weeks)

38.25 ± 2.85

39.09 ± 1.41

0.096

Infant birth weight (grams)

2881 ± 699

3209 ± 582

0.016

Infant age at V3 assessment (months)a

6.49 ± 1.19

6.22 ± 1.06

0.261

Total SES scoreb

30.8 ± 13.2

31.1 ± 12.8

0.934

Maternal BDI score (Median ± IQR)c

7.0 ± 7.0

5.5 ± 8.0

0.384

Maternal PSS score

13.4 ± 5.7

10.0 ± 4.9

0.003

n(%)

n(%)

10 (25.6)

3 (5.6)

Preterm delivery
Ethnicity:

0.013
0.385

Hispanic/Latina

23 (59.0)

37 (68.5)

Non-Hispanic/Latina

16 (41.0)

17 (31.5)

30 (76.9)

52 (96.3)

African American

2 (5.1)

0 (0.0)

American Indian

6 (15.4)

1 (1.9)

Other

1 (2.6)

1 (1.9)

Race:

0.010

White

Marital/cohabiting status:

1.000

Author Manuscript

Single/separated/divorced

17 (43.6)

23 (42.6)

Married/cohabitating

22 (56.4)

31 (57.4)

Less than high school

12 (30.8)

15 (27.8)

High school to some college

20 (51.3)

30 (55.6)

College/professional degree

7 (18.0)

9 (16.7)

Yes

8 (20.5)

17 (31.5)

No

31 (79.5)

37 (68.5)

Education Level:

0.959

Primigravida

0.343

Infant's gender:

0.403

Male

17 (43.6)

29 (53.7)

Female

22 (56.4)

25 (46.3)

5 (13.5)

9 (16.7)

BDI > 13 (%)

Author Manuscript

Family gross annual income at V3 (%)

0.695

Under $20,000

15 (38.5)

20 (37.7)

$20,000 – 39,999

13 (33.3)

14 (26.4)

$40,000 or over

11 (28.2)

19 (35.9)

21 (55.3)

19 (35.9)

Participated in early intervention program

0.774

0.087
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Sample size for specific variables might vary due to pairwise deletion of the missing data BDI, Beck Depression Inventory; median and interquartile range (IQR) is presented due to data not being normally distributed; PSS, perceived stress score

a

Age at assessment was adjusted for prematurity

Author Manuscript

b

Barratt Simplified Measure of Social Status

c

p-value reflects Wilcoxon test for difference in medians

Author Manuscript
Author Manuscript
Author Manuscript
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Table 3

Author Manuscript

Alcohol and Substance Use Patterns by Study Group (N=93)
PAE (n=39)

No-PAE (n=54)

p

10.31 ± 7.74

0.57 ± 0.74

<0.001

21 (53.9)

0 (0.0)

<0.001

AA/day (Mean ± SD)

1.27 ± 2.16

0.0026 ± 0.009

<0.001

AA/drinking day (Mean ± SD)

3.17 ± 2.09

0.86 ± 0.42a

<0.001

Number of binge episodes (Mean ± SD)

7.24 ± 8.97

0±0

<0.001

AA/day (Mean ± SD)

0.05 ± 0.25

0±0

0.237

AA/drinking day (Mean ± SD)

2.11 ± 2.49

N/A

N/A

Number of binge episodes (Mean ± SD)

0.21 ± 1.13

0±0

0.263

GGT (>40 U/L): n (%)

9 (23.1)

0 (0.0)

<0.001

PEth (≥ 8 ng/ml): n (%)

4 (10.3)

0 (0.0)

0.028

%dCDT > 2: n (%)

2 (5.1)

0 (0.0)

0.173

Alcohol Use:
12 months prior to enrollment:
AUDIT past 12 months: (Mean ± SD)
AUDIT ≥ 8: n (%)
Periconceptional period (1 month around LMP):

Alcohol use at V1:

Author Manuscript

Maternal alcohol biomarkers at V1:

Alcohol use at V2:
AA/day (Mean ± SD)

0.004 ± 0.014

0±0

0.077

AA/drinking day (Mean ± SD)

0.97 ± 0.90

N/A

N/A

Number of binge episodes (Mean ± SD)

0.03 ± 0.16

0±0

0.324

GGT (>40 U/L): n (%)

4 (10.3)

0 (0.0)

0.028

PEth (≥ 8 ng/ml): n (%)

3 (7.7)

0 (0.0)

0.070

UEtG (≥ 38 ng/ml): n (%)

3 (7.7)

0 (0.0)

0.070

UEtS (≥ 7.2 ng/ml): n (%)

9 (23.1)

0 (0.0)

<0.001

%dCDT > 2: n (%)

3 (7.7)

0 (0.0)

0.070

PEth-DBS (≥ 25 ng/ml)

7 (18.0)

0 (0.0)

0.002

Maternal alcohol biomarkers at V2:

Author Manuscript

Cumulative Alcohol use across pregnancy & periconceptional period:
AA/day (Mean ± SD)

0.44 ± 0.72

0.001±0.004

<0.001

AA/drinking day (Mean ± SD)

3.10 ± 2.12

0.86 ± 0.42a

<0.001

21 (53.9)

0 (0.0))

<0.001

Positive for ≥1 biomarker (V1 or V2) n (%)

Substance Use*:

Author Manuscript

MAT (methadone, buprenorphine):

22 (56.4)

19 (35.2)

0.057

Other opioids (heroin or Rx opioids**):

14 (35.9)

11 (20.4)

0.105

Marijuana:

14 (35.9)

6 (11.1)

0.005

Any tobacco use:

21 (53.9)

15 (27.8)

0.017

MAT, medication assisted therapy; AA, absolute ounces of alcohol (1 standard drink equals approximately 0.5 AA) GGT, gammaglutamyltranspeptidase; PEth, phosphatidylethanol; UEtG, urine ethyl glucuronide; UEtS, urine ethyl sulfate; %dCDT, disialo carbohydrate
deficient transferrin; DBS, dried blood spot
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sample size is limited to 5 controls who reported light drinking around LMP

*

Either self-reported anytime in pregnancy or a positive urine drug panel at V1 or V2

**

Author Manuscript

used either as prescribed or recreational use
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Table 4

Author Manuscript

Infant Developmental and Behavioral Outcomes by Study Group (N=93)
Infant Outcomes

PAE (n=39)

No-PAE (n=54)

Mean ± SD

Mean ± SD

p

BSID-III: Cognitive

102.4 ± 7.5

101.3 ± 9.3

0.558

BSID-III: Language

101.1 ± 6.7

99.7 ± 7.1

0.337

BSID-III: Motor

97.0 ± 11.2

96.4 ± 11.9

0.821

Parent-child dysfunctional interaction %

36.6 ± 28.1

24.0 ± 19.7

0.019

Parental distress %

37.8 ± 26.6

31.3 ± 30.1

0.285

Difficult child %

30.1 ± 25.9

17.6 ± 17.7

0.011

Total stress %

32.5 ± 26.2

19.6 ± 19.1

0.011

Surgency

65.9 ± 10.4

61.7 ± 11.7

0.081

Negative affect

50.8 ± 11.9

43.5 ± 13.9

0.011

Effortful control

65.9 ± 8.6

65.1 ± 9.9

0.717

0.184

Parenting Stress Index:

Infant Behavior Questionnaire:

Author Manuscript

Infant Sensory Profile:
Low registration performance

n (%)

n (%)

Less than others

5 (13.5)

16 (30.8)

Typical performance

22 (59.5)

25 (48.1)

More than others

10 (27.0)

11 (21.2)

0 (0)

0 (0)

Typical performance

24 (64.9)

32 (61.5)

More than others

13 (35.1)

20 (38.5)

2 (5.4)

2 (3.9)

Typical performance

21 (56.8)

39 (75.0)

More than others

14 (37.8)

11 (21.2)

Less than others

4 (10.8)

2 (3.9)

Typical performance

25 (67.6)

40 (76.9)

More than others

8 (21.6)

10 (19.2)

Sensation seeking performance

0.826

Less than others

Author Manuscript

Sensory sensitivity performance

0.168

Less than others

Sensation avoiding performance

0.436

BSID, Bayley Scales of Infant Development –III

Author Manuscript
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Table 5

Author Manuscript

Effect of PAE on Infant Developmental and Behavioral Outcomes
Infant Outcomes

β̂

β̂

(unadjusted)

(adjusteda)

η2p
Detectable
effect size

BSID-III: Cognitive

1.06

3.44#

0.0371

BSID-III: Language

1.41

1.69

0.0132

BSID-III: Motor

0.56

4.22

0.0306

Parent-child dysfunctional interaction %

12.7*

9.64#

0.0418

Parental distress %

6.49

7.52

0.0153

Difficult child %

12.5**

13.9*

0.0752

Total stress %

12.9**

13.9*

0.0822

Surgency

4.23#

4.91#

0.0438

Negative affect

7.33*

8.60**

0.0935

0.73

−0.23

0.0001

Parenting Stress Index:

Author Manuscript

Infant Behavior Questionnaire:

Effortful control
Infant Sensory Profile:

OR (95% CI)

Low registration (atypical vs typical)

0.63 (0.27, 1.48)

0.62 (0.20, 1.91)

--b

Sensation seeking (atypical vs typical)

0.87 (0.36, 2.08)

0.54 (0.16, 1.80)

--

Sensory sensitivity (atypical vs typical)

2.29# (0.93, 5.64)

2.10 (0.69, 6.40)

--

Sensation avoiding (atypical vs typical)

1.60 (0.62, 4.11)

2.06 (0.63, 6.76)

--

β̂ is the coefficient of the PAE variable

Author Manuscript

**

p<0.01;

*

p<0.05;

#

p<0.10

a

Adjusted for infant sex, birth weight, single vs. two-parent household, Beck Depression Inventory, maternal education, maternal age, MAT,
marijuana, tobacco use, and Perceived Stress Scale score during pregnancy

b

The effect size measure for the logistic regression is odds ratio, which are presented in other columns of the table

Author Manuscript
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